Hypertension Journal

Register      Login

Table of Content

2017 | July-September | Volume 3 | Issue 3

MECHANISMS

Brent M Egan

Increased Sympathetic Drive, Elevated Heart Rate, and the Cardiovascular Continuum

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:8] [Pages No:105 - 112]

   DOI: 10.5005/jp-journals-10043-0080  |  Open Access |  How to cite  | 

Abstract

How to cite this article

Egan BM. Increased Sympathetic Drive, Elevated Heart Rate, and the Cardiovascular Continuum. Hypertens J 2017;3(3):105-112.

MECHANISMS

Tiny Nair, Akash Nair

Hypertension in Pregnancy: Do We need a New Algorithm?

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:5] [Pages No:113 - 117]

   DOI: 10.5005/jp-journals-10043-0081  |  Open Access |  How to cite  | 

Abstract

How to cite this article

Nair T, Nair A. Hypertension in Pregnancy: Do We need a New Algorithm? Hypertens J 2017;3(3):113-117.

MECHANISMS

Amal K Banerjee

Biomarkers in Congestive Heart Failure: Clinical Importance

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:7] [Pages No:118 - 124]

   DOI: 10.5005/jp-journals-10043-0082  |  Open Access |  How to cite  | 

Abstract

How to cite this article

Banerjee AK. Biomarkers in Congestive Heart Failure: Clinical Importance. Hypertens J 2017;3(3):118-124.

SPECIAL SITUATIONS

Brent M Egan

Treatment-Resistant Hypertension: A Pragmatic Management Approach

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:6] [Pages No:125 - 130]

   DOI: 10.5005/jp-journals-10043-0083  |  Open Access |  How to cite  | 

Abstract

How to cite this article

Egan BM. Treatment-Resistant Hypertension: A Pragmatic Management Approach. Hypertens J 2017;3(3):125-130.

SPECIAL SITUATIONS

Richard J Auchus

Clinical and Laboratory Assessment of Patients with Suspected Primary Aldosteronism

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:8] [Pages No:131 - 138]

   DOI: 10.5005/jp-journals-10043-0084  |  Open Access |  How to cite  | 

Abstract

How to cite this article

Auchus RJ. Clinical and Laboratory Assessment of Patients with Suspected Primary Aldosteronism. Hypertens J 2017;3(3):131-138.

SPECIAL SITUATIONS

Mohan V Deshpande, Niteen V Deshpande

Assessment of End Organ Damage in Hypertension—Left Ventricular Hypertrophy

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:8] [Pages No:139 - 146]

   DOI: 10.5005/jp-journals-10043-0085  |  Open Access |  How to cite  | 

Abstract

How to cite this article

Deshpande MV, Deshpande NV. Assessment of End Organ Damage in Hypertension—Left Ventricular Hypertrophy. Hypertens J 2017;3(3):139-146.

CARDIOVASCULAR THERAPEUTICS

Nidhi Mishra, Prabhash C Manoria

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Ready to Target Atherosclerotic Cardiovascular Disease beyond Statins

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:7] [Pages No:147 - 153]

   DOI: 10.5005/jp-journals-10043-0086  |  Open Access |  How to cite  | 

Abstract

How to cite this article

Manoria PC, Mishra N. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Ready to Target Atherosclerotic Cardiovascular Disease beyond Statins. Hypertens J 2017;3(3):147-153.

CARDIO DIABETES

M Rajasekara Chakravarthi, Hari K Marri

Renal Effects of Sodium-glucose-linked Transporter 2 Inhibitors

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:7] [Pages No:154 - 160]

   DOI: 10.5005/jp-journals-10043-0087  |  Open Access |  How to cite  | 

Abstract

How to cite this article

Chakravarthi MR, Marri HK. Renal Effects of Sodium-glucose-linked Transporter 2 Inhibitors. Hypertens J 2017;3(3):154-160.

CARDIO DIABETES

Shamanna S Iyengar

Cardiovascular Protective Actions of Sodium Glucose Cotransporter 2 Inhibitors

[Year:2017] [Month:July-September] [Volume:3] [Number:3] [Pages:5] [Pages No:161 - 165]

   DOI: 10.5005/jp-journals-10043-0088  |  Open Access |  How to cite  | 

Abstract

“Current management of diabetes is characterized by opportunities, options, and obstacles.”

—Dr Sanjay Kalra

(2014)

How to cite this article

Iyengar SS. Cardiovascular Protective Actions of Sodium Glucose Cotransporter 2 Inhibitors. Hypertens J 2017;3(3):161-165.

© Jaypee Brothers Medical Publishers (P) LTD.